Physician profile
Andrew Chang
NPI 1760640791
$14,539.75
in general payments reported to CMS, 2019-2025
47 companies · $1,564 in 2025
The $1,564 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,904 · 2020: $815 · 2021: $3,049 · 2022: $1,249 · 2023: $1,264 · 2024: $1,694 · 2025: $1,564.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,522.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $2,997.21 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $2,077.10 | 2019-2025 | Provenge |
| Axonics, INC. | $1,367.59 | 2021-2022 | |
| Teleflex LLC | $1,115.35 | 2021-2025 | Urolift, Barrigel |
| Uromedica, Incorporated | $990.69 | 2019-2020 | |
| Janssen Biotech, INC. | $780.44 | 2019-2024 | Erleada, Akeega, Abiraterone Acetate |
| Boston Scientific Corporation | $724.96 | 2019-2025 | Ams 800 Artificial Urinary Sphincter, Ams 700, General - Erectile Dysfunction |
| Sumitomo Pharma America, INC. | $449.02 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $356.63 | 2019-2025 | Botox |
| Astellas Pharma US INC | $321.57 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $298.26 | 2021-2024 | Welireg, Keytruda, Lynparza |
| Olympus America INC. | $296.37 | 2021-2025 | Itind System, Bovie, Oes Cystonephrofiberscope |
| Blue Earth Diagnostics | $288.08 | 2019-2024 | |
| Accord Healthcare, INC. | $238.32 | 2022 | |
| Myriad Genetic Laboratories, INC. | $218.32 | 2021-2025 | Prolaris |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.